RecruitingNot ApplicableNCT05382663
The Jordan Study for End-Stage Renal Disease Subjects
Non-Invasive Monitoring of End-Stage Renal Disease Subjects Using Alio Medical Remote Monitoring System (RMS)
Sponsor
Alio, Inc.
Enrollment
75 participants
Start Date
Mar 21, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
To compare the Alio device to blood draws.
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- and older
- maintenance dialysis for ESRD via AVF/AVG in an arm location for at least 6 months
- written informed consent
- able to wear the SmartPatch as instructed and follow study protocols
Exclusion Criteria6
- Skin near the proximity of Patch placement is swollen, infected and/or inflamed
- pregnancy
- serious medical condition which in the opinion of the investigator may adversely affect the safety of the subject or the device being evaluated
- AVF/AVG in a non-arm location
- participants with novel indications for their AVG (ie. HeRO grafts)
- participation in any other clinical trials that could affect the quality of study data
Interventions
DEVICEAlio Device
Non-invasive device worn over vasculature.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05382663
Related Trials
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
NCT0463491617 locations
CAPABLE Transplant
NCT063269051 location
Solv Multi-Pass Hemodialysis System In-Center Clinical Study
NCT072168851 location
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
NCT070208321 location
CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients
NCT057265265 locations